Latest news with #MichaelChen
Yahoo
3 days ago
- Business
- Yahoo
Ballard Power announces results of 2025 Annual General Meeting of Shareholders
VANCOUVER, BC, June 5, 2025 /CNW/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced results of its 2025 Annual General Meeting, which was held on June 4th. All nominees listed in the Management Proxy Circular dated April 7th, 2025 were elected as directors of the Company. Each of the Ballard directors was re-elected by a majority of the votes cast by shareholders present or represented by proxy. Director biographies are available in the "Our Leadership" section of the Company's website. Director Nominee Votes For % For Votes Withheld % Withheld Kathy Bayless 84,684,573 97.71 1,988,964 2.29 Michael Chen 84,336,534 97.30 2,337,005 2.70 Jacqueline Dedo 78,793,325 90.91 7,880,214 9.09 Douglas P. Hayhurst 78,041,127 90.04 8,632,412 9.96 Randy MacEwen 84,892,738 97.95 1,780,800 2.05 Hubertus M. Muehlhaeuser 77,913,248 89.89 8,760,291 10.11 Marty Neese 84,225,903 97.18 2,447,635 2.82 James Roche 84,789,591 97.83 1,883,947 2.17 Yingbo Wang 84,290,998 97.25 2,382,540 2.75 Janet Woodruff 77,861,876 89.83 8,811,662 10.17 In addition, KPMG LLP, Chartered Accountants, was re-appointed as auditor for the Company, and an advisory vote approved the approach to executive compensation. Details of each of these resolutions are included in the Company's Management Proxy Circular. Item Votes For % For VotesAgainst % Against Withheld/ Abstain % Withheld/ Abstain Appointment of Auditors 88,666,862 85.24 - - 15,351,003 14.76 Executive Compensation 76,971,303 88.81 9,702,236 11.19 - - About Ballard Power Systems Ballard Power Systems' (NASDAQ: BLDP; TSX: BLDP) vision is to deliver fuel cell power for a sustainable planet. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, and stationary power. To learn more about Ballard, please visit Further Information Ballard Power Systems:Sumit Kundu –Investor Relations, +1.604.453.3517 or investors@ View original content to download multimedia: SOURCE Ballard Power Systems Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
06-05-2025
- Business
- Business Wire
Nuclera Establishes Distribution Network Across APAC and the Middle East
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, today announced that it has established a distribution network across APAC and the Middle East. Marking a key milestone in the Company's global commercial strategy, the expansion establishes new regional distribution networks, providing localized technical support for customers in these key markets. In response to the rapidly growing demand for its innovative eProtein Discovery System, Nuclera has formed partnerships with seven channel partners: MineBio Life Sciences Ltd (China), Kiko Tech Co.,Ltd (Japan), CHAYON Laboratories, Inc. (South Korea), Sciencewerke Pte Ltd (Singapore), Cold Spring Biotech (Taiwan) and Yair Or Technologies Ltd (Israel). These new partnerships follow the recent expansion of the eProtein Discovery System, which now enables discovery of both membrane and soluble proteins 1. Proteins represent 95% of drug targets designed to combat disease 2 therefore developing reliable and efficient methods to identify how to express soluble and active proteins of interest is a crucial aspect of the drug discovery process. Researchers are realizing the value of systems, such as eProtein Discovery, that streamline protein production and enable rapid, scalable access to high-quality proteins, across cell-free and cell-based expression methods. 'Expanding into APAC and the Middle East, in response to growing global demand, demonstrates the potential of eProtein Discovery to revolutionize the way proteins are made,' Said Dr Michael Chen, CEO and co-founder, Nuclera. 'Testament to the growing demand are installations of eProtein Discovery at leading pharma and academic institutions and the first installation of our System within a CRO. We have partnered with established partners across key markets to enable specialized local support for our customers, enabling them to make proteins for drug discovery more efficiently and effectively.' Joseph Bertelsen, CCO, Nuclera, commented: 'We are excited to have extended our reach to the Middle East and Asia through partnering with key distributors Yair Or Technologies, Minebio, Chayon Laboratories, Kiko-Tech, ScienceWerke, and Cold Spring Biotech. Establishing these distribution channels supports our goal of global expansion and comes at a pivotal time for the Company as we are focused on ramping-up commercially following the successful close of our series C fundraising round.'
